Sarepta Therapeutics(DE:AB3A)
€15.16-0.58 (-3.68%)
DE:AB3A
Sarepta Therapeutics Revenue
€15.16
At close:-0.58 (-3.68%)
Sarepta Therapeutics (AB3A) Revenue
6 Followers
Sarepta Therapeutics Revenue
Sarepta Therapeutics had a revenue of 381.35M in the quarter ending Sep 30, 2026, with -4.96%. This bring the company's revenue in the last twelve months to 1.96B, Decreased 0.91%. In the fiscal year ending Dec 31, 2025, Sarepta Therapeutics had annual revenue of 2.20B with 15.58% growth.
- Revenue (ttm)
- 1.96B
- Revenue Growth
- -23.76%
- P/S Ratio
- 0.72
- Revenue/Employee
- EUR 2,632,619
- Employees
- 835
- Market Cap
- EUR 1.59B
Revenue Chart
Sarepta Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.20B | 296.26M | 15.58% |
| Dec 31, 2024 | 1.90B | 658.64M | 52.97% |
| Dec 31, 2023 | 1.24B | 310.32M | 33.26% |
| Dec 31, 2022 | 933.01M | 231.13M | 32.93% |
| Dec 31, 2021 | 701.89M | 161.79M | 29.96% |
| Dec 31, 2020 | 540.10M | 159.27M | 41.82% |
| Dec 31, 2019 | 380.83M | 79.80M | 26.51% |
| Dec 31, 2018 | 301.03M | 146.45M | 94.74% |
| Dec 31, 2017 | 154.58M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.